Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.55 |
| ▸ | BAD | Q92934 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | LPL | P06858 | 1/20 | 0.44 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.42 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.42 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.42 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10300262 | 1.00 | BCL2L1 (0.55) | BCL2L1BADNPC1RAB9AMAOB | |
| SCHEMBL12562793 | 1.00 | BCL2L1 (0.55) | BCL2L1BADNPC1RAB9AMAOB | |
| SCHEMBL10337645 | 1.00 | BCL2L1 (0.55) | BCL2L1BADNPC1RAB9AMAOB | |
| SCHEMBL19423241 | 0.89 | BCL2L1 (0.48) | BCL2L1BADNPC1RAB9AMAOB | |
| SCHEMBL2944704 | 0.89 | BCL2L1 (0.48) | BCL2L1BADNPC1RAB9AMAOB | |
| SCHEMBL7938359 | 0.86 | ALDH1A1 (0.60) | BCL2L1BADPOLB | |
| SCHEMBL412237 | 0.86 | ALDH1A1 (0.60) | BCL2L1BADPOLB | |
| SCHEMBL12444110 | 0.86 | ALDH1A1 (0.60) | BCL2L1BADPOLB | |
| SCHEMBL13499 | 0.85 | — | — | |
| SCHEMBL7929388 | 0.83 | NPC1 (0.60) | BCL2L1BADNPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 501 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250278022-A1 | COMPOUND, POLYMERIC COMPOUND, RESIST COMPOSITION, AND METHOD OF FORMING RESIST PATTERN | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-09-04 | — | — | US | claimed |
| CN-119751825-A | Proton exchange membrane, preparation method and application thereof | 国家电投集团氢能科技发展有限公司 | 2025-04-04 | — | — | CN | claimed |
| US-20240339730-A1 | ELECTROCHEMICAL DEVICE | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2024-10-10 | — | — | US | claimed |
| EP-4411963-A2 | ELECTROCHEMICAL DEVICE | Ningde Amperex Technology Ltd. (CN) | 2024-08-07 | — | — | EP | claimed |
| US-12057602-B2 | Electrochemical device | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2024-08-06 | — | — | US | claimed |
| EP-3966880-B1 | ELECTROCHEMICAL DEVICE | NINGDE AMPEREX TECHNOLOGY LTD (CN) | 2024-07-31 | — | — | EP | claimed |
| CN-117630237-A | Method for non-targeted screening of semi-volatile residual substances in composite membrane for infant milk powder and internal standard composition | 内蒙古伊利实业集团股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| US-20230198096-A1 | ELECTROCHEMICAL DEVICE | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2023-06-22 | — | — | US | claimed |
| US-11637319-B2 | Electrolytic solution and electrochemical device | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2023-04-25 | — | — | US | claimed |
| US-11578051-B2 | Thiophene carboxamide derivative and plant disease control agent comprising same | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2023-02-14 | — | — | US | claimed |
| WO-2007006300-A1 | PRODUCTION OF MONOMER, OLIGOMER AND POLYMER PHOSPHONIC ACID ESTERS AND PHOSPHONIC AND SULPHONIC ACIDS BY A NUCLEOPHILE AROMATIC SUBSTITUTION | Universität Stuttgart (DE) | 2007-01-18 | — | — | WO | claimed |
| WO-2006066569-A2 | IONOMERS AND IONOMER BLENDS BASED ON PARTIALLY FLUORINATED POLY(HETERO)ARYLS | HÄRING, Thomas (DE) | 2006-06-29 | — | — | WO | claimed |
| US-5897940-A | Ink jet transparencies | XEROX CORPORATION (US) | 1999-04-27 | — | — | US | claimed |
| US-5744273-A | Laminatable backing substrates containing fluoro compounds for improved toner flow | XEROX CORPORATION (US) | 1998-04-28 | — | — | US | claimed |
| EP-0687671-B1 | Method for the preparation of 4-fluorothiophenol | BAYER AG (DE) | 1997-09-10 | — | — | EP | claimed |
| US-5659088-A | Process for the preparation of 4-fluorothiophenol | BAYER AKTIENGESELLSCHAFT (DE) | 1997-08-19 | — | — | US | claimed |
| US-5321121-A | Polybiphenylene sulfide and polyphenylene sulfide copolymers; reinforced composites | PHILLIPS PETROLEUM COMPANY (US) | 1994-06-14 | — | — | US | claimed |
| US-5219983-A | From para-dihalobenzene and bis-para-halobiphenyl | PHILLIPS PETROLEUM COMPANY (US) | 1993-06-15 | — | — | US | claimed |
| US-4956507-A | GRIGNARD REAGENTS FROM P-HALOFLUOROBENZENE AND MAGNESIUM COUPLING TO FORM P,P*-DIFLUOROBIPHENYL | PHILLIPS PETROLEUM COMPANY (US) | 1990-09-11 | — | — | US | claimed |
| US-4775764-A | Method for preparing 4,4' difluorobiphenyl | MALLINCKRODT INC. (US) | 1988-10-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11578051-B2 | Thiophene carboxamide derivative and plant disease control agent comprising same | BROX, GTF3C4, GTF3C2 | BCL2L1 3045/4885BAD 2509/4885NPC1 2798/4885 |
| US-20250278022-A1 | COMPOUND, POLYMERIC COMPOUND, RESIST COMPOSITION, AND METHOD OF FORMING RESIST PATTERN | ABCC1, SLC11A2, RER1 | BCL2L1 2314/4885BAD 4883/4885NPC1 2152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.